Enantiomeric amphetamine compositions for the treatment of ADHD

Details for Australian Patent Application No. 2004210671 (hide)

Owner Shire Biochem Inc.

Inventors Michaels, Alex; Hodgkins, Paul; Couch, Richard A.

Agent Davies Collison Cave

Pub. Number AU-A-2004210671

PCT Pub. Number WO2004/071501

Priority 60/473,925 29.05.03 US; 60/445,793 10.02.03 US

Filing date 10 February 2004

Wipo publication date 26 August 2004

International Classifications

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 009/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61P 025/00 Drugs for disorders of the nervous system

A61K 009/16 Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/071501 Priority application(s): WO2004/071501

22 November 2007 Change of Name(s) of Applicant(s), Section 104

  Shire Biochem Inc. The name of the applicant has been changed to Shire Canada Inc.

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004210675-Enzyme containing oral composition having enhanced stability

2004210668-Floor scrubber